When.com Web Search

  1. Ads

    related to: duration of response cancer prognosis meaning

Search results

  1. Results From The WOW.Com Content Network
  2. Response evaluation criteria in solid tumors - Wikipedia

    en.wikipedia.org/wiki/Response_Evaluation...

    Response evaluation criteria in solid tumors (RECIST) is a set of published rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment.

  3. Progression-free survival - Wikipedia

    en.wikipedia.org/wiki/Progression-free_survival

    Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [1] In oncology, PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically. Similarly ...

  4. Median follow-up - Wikipedia

    en.wikipedia.org/wiki/Median_follow-up

    In statistics, median follow-up is the median time between a specified event and the time when data on outcomes are gathered. The concept is used in cancer survival analyses. [citation needed] Many cancer studies aim to assess the time between two events of interest, such as from treatment to remission, treatment to relapse, or diagnosis to death.

  5. Survival rate - Wikipedia

    en.wikipedia.org/wiki/Survival_rate

    Doctors often use mean overall survival rates to estimate the patient's prognosis. This is often expressed over standard time periods, like one, five, and ten years. For example, prostate cancer has a much higher one-year overall survival rate than pancreatic cancer, and thus has a better prognosis.

  6. Limited-stage small cell lung carcinoma - Wikipedia

    en.wikipedia.org/wiki/Limited-stage_small_cell...

    The time between the start and the end of chemoradiotherapy is a predicator of survival in limited stage small cell lung cancer, prolongation leads to a decrease in overall survival of 1.9% per week. [20] Early concurrent radiochemotherapy may not be suitable for all patients.

  7. Clinical endpoint - Wikipedia

    en.wikipedia.org/wiki/Clinical_endpoint

    A cancer study may be powered for overall survival, usually indicating time until death from any cause, or disease-specific survival, where the endpoint is death from disease or death from toxicity. These are expressed as a period of time (survival duration) e.g., in months.